Assessing long-term effectiveness of MS treatment — a matter of debate

Nature Reviews Neurology, Published online: 25 February 2021; doi:10.1038/s41582-021-00476-xAssessment of the long-term effectiveness of disease-modifying therapies in multiple sclerosis is plagued by methodological issues, but statistical methods continue to evolve. Use of a novel approach has highlighted the importance of accounting for cumulative exposure to disease-modifying therapies when assessing the long-term effects of treatment on disability accumulation.
Source: Nature Reviews Neurology - Category: Neurology Authors: Source Type: research